Pharmacies Attack $68B Pfizer-Wyeth Deal In 9th Circ.
A group of pharmacies urged the Ninth Circuit on Tuesday to reinstate its challenge to Pfizer Inc.'s $68 billion merger with Wyeth, arguing the deal has resulted in higher prices and...To view the full article, register now.
Already a subscriber? Click here to view full article